anti-TL1A monoclonal antibody, high dose: clinical trials recruiting now
Fewer than 3 recruiting trials found.
2
Recruiting trials
4
Conditions studied
0
US states with sites
1
Countries
Phase breakdown
Phase 2 2
Conditions being studied
| Condition | Trials |
|---|---|
| Crohn's Disease (CD) | 1 |
| Crohn's disease | 1 |
| Ulcerative Colitis (UC) | 1 |
| Ulcerative colitis | 1 |
Recruiting trials involving anti-TL1A monoclonal antibody, high dose
- Clinical Study of the Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of BCD-261 in Subjects With Moderate to Severe Active Crohn's Disease
- Study of the Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of BCD-261 in Subjects With Moderate to Severe Active Ulcerative Colitis
Common questions
How many recruiting trials involve anti-TL1A monoclonal antibody, high dose?
2 recruiting trials across 4 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.